Wilson Sonsini Goodrich & Rosati and Goodwin advised MiroBio on the deal.MiroBio, a leader in the development of checkpoint agonists to treat autoimmune diseases, announced the…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Martina Bellini
…
This content is for Standard 1 Year members only. LoginJoin Now